Bethel Tesfai Embaie
Bethel Tesfai Embaie graduated in 2018 with a Bachelor’s Degree in Biomedicine from Karolinska Institutet. During her studies, she took the opportunity to do an international exchange semester in Leiden University Medical Center, which was a great platform for clinical and translational research education due to the proximity to the hospital. Within the first year of her studies, she was a part of the International Genetically Engineered Machine (iGEM) competition in synthetic biology founded at the Massachusetts Institute of Technology. Their multidisciplinary iGEM group focused on tackling the issue of chronic wounds and antibiotic resistance, using recombinant proteins to inhibit or disperse S. aureus and P. aeruginosa biofilm, at KTH Royal Institute of Technology. She performed her bachelor thesis at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet in Birgitta Henriques Normark’s group, characterizing the virulence and localization of pneumococcal surface protein, as a potential vaccine candidate. She is currently a Master student in the Baryawno lab, focusing on single-cell RNA data of neuroblastoma and targeting chemo-resistant tumor cells.